Founded
Address
Vivo Ventures LLC
575 High Street
Suite 201
Palo Alto, CA 94301
United States
Phone
Website
Recent investment activity
KANDO id: 30821
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 49 of 49| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Revance Therapeutics Inc | Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. | Series D | |||
|
|
Sagent Pharmaceuticals | Is an international specialty injectable pharmaceutical company bringing finished pharmaceutical products to the U.S. market. | N/A | |||
|
|
Synapse Biomedical Inc | Provider of neurostimulation technology designed to help spinal cord injury patients decrease their dependency on mechanical ventilation. | N/A | |||
|
|
Transcept Pharmaceuticals Inc | Series D | ||||
|
|
Transcept Pharmaceuticals Inc | Series C | ||||
|
|
Tranzyme Pharma | Drug discovery and development, focused on gastroenterology indications | N/A | |||
|
|
TRIA Beauty Inc | Venture | ||||
|
|
TRIA Beauty Inc | Series E | ||||
|
|
Vicept Therapeutics Inc | Series A | ||||
|
|
ViOptix Inc | Develops, manufactures and markets innovative proprietary products for tissue oximetry, measuring oxygen saturation levels in tissues. | Series C | |||
|
|
YM Biosciences Inc | N/A | ||||
|
|
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | |||
|
|
Acura Pharmaceuticals | Pharmaceutical company | N/A | |||
|
|
AirXpanders | A medical device company that has developed the AeroForm tissue expander. | Series D | |||
|
|
APT Pharmaceuticals Inc | A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. | Series A Initial investment | |||
|
|
Ceptaris Therapeutics Inc | Specialty pharmaceuticals company. | Series D | |||
|
|
Cubist Pharmaceuticals Inc | Cubist Pharmaceuticals is a bio-pharmaceutical company. | N/A | |||
|
|
InteKrin Therapeutics Inc | Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. | Series C | |||
|
|
Keryx Biopharmaceuticals Inc | N/A | ||||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A | |||
|
Neomend Inc | A biomedical device company, engages in the development and commercialization of surgical wound healing products | Series D | |||
|
|
Nextwave Pharmaceuticals Inc | Specialty pharmaceutical company, focused on pediatric neurology. | N/A | |||
|
|
Rempex Pharmaceuticals Inc | Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. | Series B Initial investment | |||
|
|
SentreHEART Inc | A medical device company that has developed catheter-based solutions to address unmet clinical needs. | Series C Initial investment |